Released Jun 14, 2017, after the close
10-Q filed Jun 14, 2017, 45 days after period end · 0001654954-17-005564
Q2 2017 · 10-Q
Revenue$3.92M$3.92M no prior Q2 2016 on fileno prior Q1 2017 on file
Net Income-$322.76K-$322.76K N/M vs Q2 2016N/M vs Q1 2017
EPS Diluted-$0.01-$0.01 N/M vs Q2 2016N/M vs Q1 2017
Gross Profit$1,041,190−31.7%
Operating Income-$324,568N/M
Operating Cash Flow-$909,227N/M
Free Cash Flowderived-$952,597N/M
Margins · derived
Gross margin26.6%
Operating margin-8.3%
Net margin-8.2%
What the release said
The release
Same quarter
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | $3.92M | — | — | — |
| Net Income | -$322.76K | $37.20K | $359.01K | $327.78K |
| EPS Diluted | -$0.01 | $0.00 | $0.02 | $0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR